Literature DB >> 18508118

Development of photocrosslinked sialic acid containing polymers for use in Abeta toxicity attenuation.

Christopher B Cowan1, Gerard L Coté, Theresa A Good.   

Abstract

beta-Amyloid peptide (Abeta), the primary protein component in senile plaques associated with Alzheimer's disease (AD), has been implicated in neurotoxicity associated with AD. Previous studies have shown that the Abeta-neuronal membrane interaction plays a crucial role in Abeta toxicity. More specifically, it is thought that Abeta interacts with ganglioside rich and sialic acid rich regions of cell surfaces. In light of such evidence, we have hypothesized that the Abeta-membrane sialic acid interaction could be inhibited through use of a biomimic multivalent sialic acid compound that would compete with the cell surface for Abeta binding. To explore this hypothesis, we synthesized a series of photocrosslinked sialic acid containing oligosaccharides and tested their ability to bind Abeta and attenuate Abeta toxicity in cell culture assays. We show that a polymer prepared via the photocrosslinking of disialyllacto-N-tetraose (DSLNT) was able to attenuate Abeta toxicity at low micromolar concentrations without adversely affecting the cell viability. Polymers prepared from mono-sialyl-oligosaccharides were less effective at Abeta toxicity attenuation. These results demonstrate the feasibility of using photocrosslinked sialyl-oligosaccharides for prevention of Abeta toxicity in vitro and may provide insight into the design of new materials for use in attenuation of Abeta toxicity associated with AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508118      PMCID: PMC2587107          DOI: 10.1016/j.biomaterials.2008.05.001

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  57 in total

1.  Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells.

Authors:  M Aubert; L Panicot; C Crotte; P Gibier; D Lombardo; M O Sadoulet; E Mas
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

2.  The lectin-binding properties of six generations of mannose-functionalized dendrimers.

Authors:  Eric K Woller; Mary J Cloninger
Journal:  Org Lett       Date:  2002-01-10       Impact factor: 6.005

3.  A structure-function study of ligand recognition by CD22beta.

Authors:  S M van Rossenberg; L A Sliedregt; R Autar; C Piperi; A P Van Der Merwe; T J van Berkel; J Kuiper; E A Biessen
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

4.  Albumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromer.

Authors:  I S Kim; Y I Jeong; D H Kim; Y H Lee; S H Kim
Journal:  Arch Pharm Res       Date:  2001-02       Impact factor: 4.946

5.  Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide.

Authors:  R V Ward; K H Jennings; R Jepras; W Neville; D E Owen; J Hawkins; G Christie; J B Davis; A George; E H Karran; D R Howlett
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

6.  Characterization of high-affinity binding between gangliosides and amyloid beta-protein.

Authors:  T Ariga; K Kobayashi; A Hasegawa; M Kiso; H Ishida; T Miyatake
Journal:  Arch Biochem Biophys       Date:  2001-04-15       Impact factor: 4.013

7.  Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.

Authors:  Atsuko Kakio; Sei-ichi Nishimoto; Katsuhiko Yanagisawa; Yasunori Kozutsumi; Katsumi Matsuzaki
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

8.  Gangliosides inhibit the release of interleukin-1beta in amyloid beta-protein-treated human monocytic cells.

Authors:  T Ariga; M Kiso; A Hasegawa; T Miyatake
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

Review 9.  Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.

Authors:  S Varadarajan; S Yatin; M Aksenova; D A Butterfield
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

10.  Affinity-based inhibition of beta-amyloid toxicity.

Authors:  Christopher W Cairo; Andrea Strzelec; Regina M Murphy; Laura L Kiessling
Journal:  Biochemistry       Date:  2002-07-09       Impact factor: 3.162

View more
  3 in total

1.  Exploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.

Authors:  Christopher B Cowan; Dhara A Patel; Theresa A Good
Journal:  J Theor Biol       Date:  2009-02-13       Impact factor: 2.691

2.  Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.

Authors:  Hovig Kouyoumdjian; David C Zhu; Mohammad H El-Dakdouki; Kelly Lorenz; Jianjun Chen; Wei Li; Xuefei Huang
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

3.  An Oligomannuronic Acid-Sialic Acid Conjugate Capable of Inhibiting Aβ42 Aggregation and Alleviating the Inflammatory Response of BV-2 Microglia.

Authors:  Jianrong Wu; Miaosen Wu; Hongtao Zhang; Xiaobei Zhan; Nian Wu
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.